Showing results (101-110 of 254) with videos related to
Sort By:
Pageof 26
Antiviral Research|July 18, 2020
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2Andrés Pizzorno, Blandine Padey, Julia Dubois, et al.American Journal of Infection Control|December 3, 2014
Detection of hospital outbreaks of influenza-like illness based on excess of incidence rates compared to the communityPhilippe Vanhems, Nicolas Voirin, Thomas Bénet, et al.Gastroenterologie Clinique Et Biologique|October 11, 2007
[EBV-induced fulminant hepatic failure: favorable outcome after liver transplantation]Jérôme Dumortier, Yahia Mekki, Thomas Rimmelé, et al.Frontiers in Immunology|February 27, 2019
Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic ImmunosuppressionSuzan Dahdal, Carole Saison, Martine Valette, et al.Antimicrobial Agents and Chemotherapy|March 23, 2011
Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivirMathilde Richard, Olivier Ferraris, Alexandra Erny, et al.Journal of Virology|January 18, 2019
The Nonstructural NS1 Protein of Influenza Viruses Modulates <i>TP53</i> Splicing through Host Factor CPSF4Julia Dubois, Aurélien Traversier, Thomas Julien, et al.Scientific Reports|March 1, 2018
Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infectionAndrés Pizzorno, Julia Dubois, Daniela Machado, et al.The Pediatric Infectious Disease Journal|January 30, 2007
Influenza burden in febrile infants and young children in a pediatric emergency departmentDominique Ploin, Yves Gillet, Florence Morfin, et al.Antiviral Research|July 29, 2010
Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009Jean-Sébastien Casalegno, Maude Bouscambert-Duchamp, Valérie Caro, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 8, 2024
Post-disappearance scenarios: policy implications following the potential disappearance of B/Yamagata lineage influenza virusesMarco Del Riccio, Marta C Nunes, Benjamin J Cowling, et al.Pageof 26